FREQ
Price:
$0.2996
Market Cap:
$10.94M
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candidate is FX-322, which is in Phase IIa clinical trial to treat the underlying cause of sensorineural hearing loss. It is also developing medicines for patients across a range of degenerative conditions, including multiple sclerosis, and diseases of the muscle, gastrointestinal tract, skin, and bone. The company has a license and collaboration agreement...[Read more]
Industry
Biotechnology
IPO Date
2019-10-03
Stock Exchange
NASDAQ
Ticker
FREQ
According to Frequency Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is 187.90%. This represents a change of -979.51% compared to the average of -21.36% of the last 4 quarters.
The mean historical ROE of Frequency Therapeutics, Inc. over the last ten years is 20.91%. The current 187.90% ROE has changed 798.76% with respect to the historical average. Over the past ten years (40 quarters), FREQ's ROE was at its highest in in the December 2018 quarter at 11.28%. The ROE was at its lowest in in the March 2023 quarter at -36.70%.
Average
20.91%
Median
29.48%
Minimum
-64.73%
Maximum
68.27%
Discovering the peaks and valleys of Frequency Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 19.62%
Maximum Annual ROE = 68.27%
Minimum Annual Increase = -332.94%
Minimum Annual ROE = -64.73%
Year | ROE | Change |
---|---|---|
2022 | 31.18% | -148.16% |
2021 | -64.73% | -332.94% |
2020 | 27.79% | 19.62% |
2019 | 23.23% | -41.48% |
2018 | 39.70% | -41.85% |
The current ROE of Frequency Therapeutics, Inc. (FREQ) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-1.92%
5-year avg
11.43%
10-year avg
20.91%
Frequency Therapeutics, Inc.’s ROE is greater than Lineage Cell Therapeutics, Inc. (-35.54%), greater than MAIA Biotechnology, Inc. (-18051.81%), less than Armata Pharmaceuticals, Inc. (182.35%), greater than Portage Biotech Inc. (-267.72%), greater than PMV Pharmaceuticals, Inc. (-21.96%), greater than Olema Pharmaceuticals, Inc. (-44.18%), greater than Enochian Biosciences, Inc. (-47.54%), greater than Scholar Rock Holding Corporation (-114.96%), greater than Passage Bio, Inc. (-70.73%), greater than Shattuck Labs, Inc. (-68.65%), greater than C4 Therapeutics, Inc. (-42.45%), greater than Eliem Therapeutics, Inc. (-47.03%), greater than Prelude Therapeutics Incorporated (-59.82%), greater than Monte Rosa Therapeutics, Inc. (-70.40%), less than Absci Corporation (0%), greater than Adverum Biotechnologies, Inc. (-44.24%), greater than Kezar Life Sciences, Inc. (-65.14%), greater than Oncternal Therapeutics, Inc. (-54.50%), less than null (120.03%),
Company | ROE | Market cap |
---|---|---|
-35.54% | $158.36M | |
-18051.81% | $68.85M | |
182.35% | $85.03M | |
-267.72% | $5.25M | |
-21.96% | $84.49M | |
-44.18% | $679.18M | |
-47.54% | $45.38M | |
-114.96% | $2.50B | |
-70.73% | $37.34M | |
-68.65% | $55.36M | |
-42.45% | $455.30M | |
-47.03% | $342.68M | |
-59.82% | $66.03M | |
-70.40% | $542.54M | |
0% | $454.22M | |
-44.24% | $156.84M | |
-65.14% | $51.73M | |
-54.50% | $4.38M | |
120.03% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Frequency Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Frequency Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Frequency Therapeutics, Inc.'s ROE?
How is the ROE calculated for Frequency Therapeutics, Inc. (FREQ)?
What is the highest ROE for Frequency Therapeutics, Inc. (FREQ)?
What is the 3-year average ROE for Frequency Therapeutics, Inc. (FREQ)?
What is the 5-year average ROE for Frequency Therapeutics, Inc. (FREQ)?
How does the current ROE for Frequency Therapeutics, Inc. (FREQ) compare to its historical average?